CD34 and ischemic cardiomyopathy: Ischemic cardiomyopathy (ICM) refers to a condition in which the left ventricular myocardium is injured due to CAD, followed by pathological fibrosis at the injury site, resulting in a decrease in LVEF.46–48) Based on the results of nonclinical studies introduced in the AMI and Refractory Angina sections, CD34+ cell therapy for ICM has been attempted.